Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AIFA · 1 medicine
CBG-MEB · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ghryvelin (previously Macimorelin Aeterna Zentaris) | European Union | Authorised | Atnahs Pharma Netherlands B.V. | ||
| Macrilen | United States | 60MG BASE/POUCH | for solution | Not marketed | Aeterna Zentaris |
| Ghryvelin | Croatia | Authorised | |||
| Ghryvelin | Italy | Granulato per sospensione orale | Authorised | Atnahs Pharma Netherlands BV | |
| Ghryvelin 60 MG Granulado Para Suspensión Oral en Sobre | Spain | 60 mg | granulado para suspensión oral | Marketed | Atnahs Pharma Netherlands Bv. |
| GHRYVELIN 60 mg granulaat voor orale suspensie in sachet | Netherlands | Granulaat voor orale suspensie | Authorised | Atnahs Pharma Netherlands B.V. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, EMA, FDA and HALMED. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
